5 Stocks to Watch: Week of 4/7/2025

Happy weekend to you! We’ve got a fresh batch of stocks that remain Strong Buys, even amid so much market uncertainty:

• Why Sprouts Farmers Market (NASDAQ: SFM) earns the coveted Stock of the Week status
• Ardent Health Partners (NYSE: ARDT) is trending after its IPO 
• The momentum could continue for pandemic winner Chewy Inc. (NYSE: CHWY)
• How EverQuote Inc. (NASDAQ: EVER) is securing handy returns
• Analysts are doubling down on Jabil Inc. (NYSE: JBL)

P.S. Did you miss last week's picks? Check them out here.

1- Sprouts Farmers Market (NASDAQ: SFM)

Our last entry for today is also our Stock of the Week. Sprouts Farmers Market is well-positioned to benefit from a healthy appetite (pun intended) for healthy, fresh, organic, farm-to-table produce. In addition, with a trade war brewing, gaining exposure to a company whose operations are tariff-proof and whose products fall under non-discretionary spending seems like a prudent choice.

Zen Rating: B (Buy) — see full analysis >  

Recent Price: $150.26  — get current quote > 

Max 1-year forecast: $200.00 

Why we’re watching:

• Sprouts Farmers Market is our Stock of the Week. Our Editor-in-Chief, Steve Reitmeister, highlighted SFM’s key strengths in a Monday article. You ought to give it a read — but we’ll provide the Cliff Notes version here.
• Over the past 5 years EPS has impressed investors with a streak of 20 straight earnings that has led to a 9X increase in the share price.
• The streak doesn’t appear like it will end any time soon — last quarter’s 7.5% beat set off a chain reaction of higher earnings estimates for this year and next by about 10%.
• So,  why did estimates go up more than the size of the beat? Steve posits that it is because there is clearly earnings momentum in their business model that points to an even brighter future.
• At present, the Street-high price target of $200 is issued by Kate McShane of Goldman Sachs (a top 14% rated analyst)
• SFM carries an overall Zen Rating of B — but qualifies in the top 10% of stocks on the whole.  
• Sprouts Farmers Market stock also boasts an impressive and wide array of strong Component Grade ratings — top 7% in Artificial Intelligence and top 8% in Financials being chief among them. SFM also ranks in the top 10% in another category — but you’ll have to take a look at Steve’s article to find out which one.
• (See all 7 Zen Component Grades here >)

2- EverQuote Inc (NASDAQ: EVER)

EverQuote operates an online marketplace, but a slightly atypical one. If you’re in the market for insurance, you might want to give the company’s platform a look. As advertising budgets across the industry are in recovery, EVER stock has already managed to secure a pretty handy return since the start of the year. With a double beat in tow, Wall Street is confident that there’s plenty of upside remaining.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $24.41 — get current quote > 

Max 1-year forecast: $38.00 

Why we’re watching:

• Out of a total of 5 analysts, 4 gave EverQuote stock a Strong Buy rating, and the odd rating out happens to be a Buy. See the ratings.
• There’s an interesting detail here — that lone Buy rating comes from Needham researcher Mayank Tandon (a top 2% rated analyst). Despite not giving the stock a Strong Buy rating, the analyst set the Street-high price target of $38, which implies a 35.28% upside, after the company’s Q4 and FY 2024 earnings.
• Tandon summarized the quarter's results as "well above expectations across the board because auto carrier marketing spend continued to recover."
• Looking ahead, the analyst noted that management's above-consensus Q1 2025 guidance reflects impressive 73% revenue growth and healthy profitability supported by the improving operating environment.
• EVER stock carries an overall Zen Rating of A — moreover, it ranks in the top 1% of all the stocks that our system tracks.
• Yet another interesting detail can be found by taking a closer look at EverQuote’s Component Grade ratings. A whopping three categories have merited an A rating — Financials, Sentiment, and Growth. Respectively, the stock ranks in the top 1%, top 1%, and top 2% in those areas. (See all 7 Zen Component Grades here >)

3- Chewy Inc (NYSE: CHWY)

This pure-play e-commerce business soared to incredible heights during the pandemic. Chewy provides everything your pets could want for, from food, treats, and toys to medication. With that said, why might you want CHWY? In the last 365 days, the stock’s price has soared by 102.2%, and although it is exposed to some tariff risks, the company is quite well-positioned, financially speaking, to weather any emerging challenges.

Zen Rating: B (Buy) — see full analysis >  

Recent Price: $33.31  — get current quote > 

Max 1-year forecast: $47.00 

Why we’re watching:

• As of early April, 15 analysts track Chewy stock and issue ratings for it — 8 of whom have deemed it a Strong Buy. The remaining ratings are split between 6 Buys and 1 Hold — so coverage is almost unanimously bullish. See the ratings
• Citigroup’s Steven Zaccone (a top 25% rated analyst) maintained a Strong Buy rating on the stock and raised his price target from $40 to $42, following the company’s Q4 and FY 2024 earnings.
• Looking ahead, Zaccone predicted that Chewy's sales momentum would continue because the company is gaining market share based on its steady auto-ship business as its customer count increased to positive low-single-digit growth, which "is a key driver for the growth story to get back on track."
• In addition, the researcher praised the strength of the fundamentals of Chewy’s business, as well as management’s “solid” guidance for FY 2025.
• CHWY stock has an overall Zen Rating of B — meaning that our rating system has identified it as an equity with a high likelihood of outperforming the wider market.
• While it ranks solidly in terms of Momentum, Financials is CHWY’s strongest suit, as it is rated in the top 8% of stocks in that regard. (See all 7 Zen Component Grades here >)

4- Ardent Health Partners Inc (NYSE: ARDT) 

Fresh off its IPO, Ardent Health Partners is still flying under the radar despite being one of the largest for-profit hospital operators in the U.S. With 30 hospitals and over 200 care sites across six states, Ardent is positioned at the intersection of regional healthcare demand and efficient, scalable operations. The price of ARDT shares has fallen significantly since they’ve gone public — and present prices present a rather attractive entry point.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $12.42— get current quote > 

Max 1-year forecast: $25.00 

Why we’re watching:

• Ardent Healthcare is currently tracked by 9 Wall Street analysts, and has 5 Strong Buy ratings, 2 Buy ratings, and 2 Hold ratings. See the ratings.
• On March 26, Stephens & Co. researcher Scott Fidel (a top 9% rated analyst) doubled down on a previously set Strong Buy rating, and kept a $22 price target on ARDT shares.
• The average 12-month price forecast for Ardent Health stock, which is slightly lower than Fidel’s at $21.78, implies an impressive 65.49% upside — so it’s clear that the Street is quite bullish.  
• Our proprietary quant rating system is in agreement, as it currently rates ARDT an A in terms of its Zen Rating, placing it in the top 5% of equities overall.
• Ardent Health is the 2nd best-rated stock in the entire Medical Care Facility industry (although it enjoys better analyst coverage, as well as a higher projected upside, when compared to the number-one rated stock in the industry).
• The stock ranks in the top 1% according to its Value Component Grade rating, and is currently trading at an enticing price-to-earnings growth (PEG) ratio of 0.73x, and a P/E of just 8.28x. (See all 7 Zen Component Grades here >)

5- Jabil Inc (NYSE: JBL)

Jabil Inc. is a crucial behind-the-scenes player helping some of the world’s biggest tech and industrial companies scale production without sacrificing speed and efficiency. It maintains a strong level of exposure to high-growth sectors such as electric vehicles and healthcare — moreover, it enjoys broad analyst support, and is currently trading at a pretty steep discount compared to a late-January high.

Zen Rating: B (Buy)  — see full analysis >  

Recent Price: $112.85  — get current quote > 

Max 1-year forecast: $184.00 

Why we’re watching:

• JBL stock is a consensus Strong Buy — with 4 Strong Buy ratings and a single Hold rating. See the ratings
• Following the company’s Q2 2025 earnings call, George Wang of Barclays (a top 19% rated analyst) doubled down on a previously-set Strong Buy rating. In addition, he hiked his price target on the stock from $179 to a Street-high of $184.
• The quarter and management's guidance both beat expectations, Wang told investors. On top of that, the analyst predicted that end markets will recover in 2H 2025 and that Jabil's growth will inflect higher in FY 2026.
• Jabil Inc. carries an overall Zen Rating of B. In fact, it ranks in the top 8% of all the stocks we track.
• While JBL has a pretty strong Sentiment Component Grade rating, as it ranks in the 88th percentile in that regard, Artificial Intelligence is its strongest rating. A neural network trained on more than 20 years of technical and fundamental data has picked up on subtle patterns that correlate with outperformance, and in terms of its AI rating, Jabil Inc stock ranks in the top 1%
• (See all 7 Zen Component Grades here >)

What to Do Next?

• 8 Stock Lists You Need Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return > 
• 4 Step Process to Find More 100%+ Stock Winners >

Want to get in touch? Email us at news@wallstreetzen.com.